Hypokalemic periodic paralysis due to CACNA1S gene mutation

Neurosciences (Riyadh). 2019 Jul;24(3):225-230. doi: 10.17712/nsj.2018.3.20180005.

Abstract

Hypokalemic periodic paralysis (HypoPP) is a relatively rare but treatable disorder caused by mutations in the CACNA1S gene. HypoPP patients may experience paralytic episodes associated with hypokalemia and, infrequently, may develop late-onset proximal myopathy. The paralytic attacks are characterized by reversible flaccid paralysis and, in most cases, spare the respiratory muscles and heart. We report a case of CACNA1S periodic paralysis precipitated by vigorous exercise in a 14-year-old boy who presented with sudden-onset paralysis of both his upper and lower extremities. Laboratory evaluation revealed a markedly low serum potassium level. The patients symptoms resolved after correction of the potassium abnormality, and he was discharged with no neurological deficits. Although rare, HypoPP must be differentiated from other causes of weakness and paralysis so that proper treatment can be promptly initiated to ensure good outcomes.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Calcium Channels, L-Type / genetics*
  • Electrocardiography
  • Humans
  • Hypokalemic Periodic Paralysis / diagnosis*
  • Hypokalemic Periodic Paralysis / genetics
  • Male
  • Mutation, Missense

Substances

  • CACNA1S protein, human
  • Calcium Channels, L-Type